Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - EPS
EPS AKBA - Akebia Therapeutics, Inc.
-0.28
LAST VALUE
56.50%
2 YEAR CAGR
28.23%
5 YEAR CAGR
8.49%
10 YEAR CAGR